Comparing bleeding risks in tracheotomy patients on antiplatelet therapy
Evaluation of the Safety of Percutaneous Tracheotomies in Intensive Care Patients With and Without Antiplatelet Therapy and Comparison of Two Tracheotomy Techniques
This study tests how safe it is to perform tracheotomies on critically ill patients who are taking two blood-thinning medications and if different techniques affect the risk of bleeding.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Asklepios Neurological Clinic Bad Salzhausen Academic / other |
| Locations | 1 site (Nidda) |
| Trial ID | NCT05058469 on ClinicalTrials.gov |
What this trial studies
This study investigates the incidence of bleeding and complications associated with percutaneous dilatative tracheostomy (PDT) in patients receiving dual antiplatelet therapy. It focuses on critically ill patients who require long-term ventilation and examines how different techniques of PDT may influence outcomes. By observing these patients, the study aims to provide insights into the safety of performing tracheotomies in this specific population. The findings could help inform clinical practices regarding tracheotomy procedures in patients on antiplatelet medications.
Who should consider this trial
Good fit: Ideal candidates for this study are critically ill patients who have undergone percutaneous dilatational tracheostomy.
Not a fit: Patients who do not require tracheostomy or are not on antiplatelet therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the safety of tracheotomy procedures in patients requiring antiplatelet therapy, potentially reducing complications.
How similar studies have performed: While there may be studies on tracheostomy complications, this specific investigation into the effects of dual antiplatelet therapy on PDT is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent Percutaneous Dilational Tracheostomy Exclusion Criteria: * none
Where this trial is running
Nidda
- Neurologische Klinik Bad Salzhausen — Nidda, Germany (Recruiting)
Study contacts
- Study coordinator: Dirk Bandorski, MD
- Email: d.bandorski@asklepios.com
- Phone: +496043804212
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.